Turkey
Hanay Advanced Chemicals Inc., founded in 2020 and headquartered in Turkey, operates at the intersection of the Biotechnology and Pharmaceutical industries. The company prides itself on its specialized offering: Amino acid based polymers, hydrogels and hybrid gels.
With a focus on innovation, Hanay provides critical chemical components such as synthetic polypeptides, N-carboxyanhydride monomers, and triazolinedione crosslinkers. These offerings are foundational in the creation of synthetic polypeptide hydrogels, reflecting their strategic aim to advance biochemical applications.
Despite being a relatively young company, Hanay secured a $20.00K seed investment on 01 June 2022, which is an early indicator of confidence in their potential within the market, though the specific investors remain undisclosed. This funding supports Hanay's growth-oriented ambitions to expand its presence and impact in the global biotech and pharma sectors.
